These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Importance of specific prostatic antigen to prostatic volume ratio in the selection of patients for ultrasonography-guided biopsy of the prostate]. Veneziano S; Pavlica P; Querzè R; Viglietta G; Trenta A Radiol Med; 1991 Jun; 81(6):857-60. PubMed ID: 1713333 [TBL] [Abstract][Full Text] [Related]
3. Volume of normal prostate, of prostate cancer, and of benign prostatic hyperplasia: are correlations with prostate specific antigen clinically useful? Clements R; Penney MD; Etherington RJ; Griffiths GJ; Hughes H; Peeling WB Prostate Suppl; 1992; 4():51-7. PubMed ID: 1374178 [TBL] [Abstract][Full Text] [Related]
4. Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer. Lee F; Littrup PJ; Loft-Christensen L; Kelly BS; McHugh TA; Siders DB; Mitchell AE; Newby JE Cancer; 1992 Jul; 70(1 Suppl):211-20. PubMed ID: 1376190 [TBL] [Abstract][Full Text] [Related]
5. [Results of studies of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hypertrophy and prostatic cancer]. Romics I; Bodrogi I; Frang D Orv Hetil; 1995 Jul; 136(30):1599-602. PubMed ID: 7543669 [TBL] [Abstract][Full Text] [Related]
6. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025 [TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis. van Iersel MP; Witjes WP; de la Rosette JJ; Oosterhof GO Br J Urol; 1995 Jul; 76(1):47-53. PubMed ID: 7544204 [TBL] [Abstract][Full Text] [Related]
8. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions. Goel T; Garg S Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015 [TBL] [Abstract][Full Text] [Related]
9. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Bretton PR; Evans WP; Borden JD; Castellanos RD Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040 [TBL] [Abstract][Full Text] [Related]
10. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia. Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341 [TBL] [Abstract][Full Text] [Related]
11. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy. De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144 [TBL] [Abstract][Full Text] [Related]
12. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen]. Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of benign prostatic hyperplasia from prostate cancer using prostate specific antigen dynamic profile after transrectal prostate biopsy. Lin TP; Huang WJ; Chen KK J Urol; 2004 Jun; 171(6 Pt 1):2226-9. PubMed ID: 15126790 [TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer. Semjonow A; Hamm M; Rathert P; Hertle L Br J Urol; 1994 May; 73(5):538-43. PubMed ID: 7516808 [TBL] [Abstract][Full Text] [Related]
15. [Prostate-specific antigen in prostatic pathology]. Teillac P; Peyret C; Leroy M; Najean Y; Le Duc A Ann Urol (Paris); 1988; 22(3):193-6. PubMed ID: 2456712 [TBL] [Abstract][Full Text] [Related]
16. Changes in serum prostate-specific antigen following prostatectomy in patients with benign prostate hyperplasia. Furuya Y; Akakura K; Tobe T; Ichikawa T; Igarashi T; Ito H Int J Urol; 2000 Dec; 7(12):447-51. PubMed ID: 11168683 [TBL] [Abstract][Full Text] [Related]
17. Eosinophilic prostatitis and prostatic specific antigen. Liu S; Miller PD; Holmes SA; Christmas TJ; Kirby RS Br J Urol; 1992 Jan; 69(1):61-3. PubMed ID: 1371086 [TBL] [Abstract][Full Text] [Related]
18. Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate. Feneley MR; Webb JA; McLean A; Kirby RS Br J Urol; 1995 Jan; 75(1):14-20. PubMed ID: 7531587 [TBL] [Abstract][Full Text] [Related]
19. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617 [TBL] [Abstract][Full Text] [Related]
20. [Endorectal ultrasound of the prostate]. Chanis G; Chanis GD Rev Med Panama; 1993 May; 18(2):120-7. PubMed ID: 7687067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]